These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
561 related items for PubMed ID: 22634300
1. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadière B, Dalba C, Klatzmann D, Bellier B. Vaccine; 2013 Mar 01; 31(11):1540-7. PubMed ID: 22634300 [Abstract] [Full Text] [Related]
2. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. Desjardins D, Huret C, Dalba C, Kreppel F, Kochanek S, Cosset FL, Tangy F, Klatzmann D, Bellier B. J Gene Med; 2009 Apr 01; 11(4):313-25. PubMed ID: 19248137 [Abstract] [Full Text] [Related]
5. Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line. Earnest-Silveira L, Chua B, Chin R, Christiansen D, Johnson D, Herrmann S, Ralph SA, Vercauteren K, Mesalam A, Meuleman P, Das S, Boo I, Drummer H, Bock CT, Gowans EJ, Jackson DC, Torresi J. J Gen Virol; 2016 Aug 01; 97(8):1865-1876. PubMed ID: 27147296 [Abstract] [Full Text] [Related]
6. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice. Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z. Vaccine; 2011 May 09; 29(20):3714-23. PubMed ID: 21396407 [Abstract] [Full Text] [Related]
7. Virus-like particle-based vaccines against hepatitis C virus infection. Bellier B, Klatzmann D. Expert Rev Vaccines; 2013 Feb 09; 12(2):143-54. PubMed ID: 23414406 [Abstract] [Full Text] [Related]
10. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins. Satoi J, Murata K, Lechmann M, Manickan E, Zhang Z, Wedemeyer H, Rehermann B, Liang TJ. J Virol; 2001 Dec 09; 75(24):12121-7. PubMed ID: 11711603 [Abstract] [Full Text] [Related]
14. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. Chmielewska AM, Naddeo M, Capone S, Ammendola V, Hu K, Meredith L, Verhoye L, Rychlowska M, Rappuoli R, Ulmer JB, Colloca S, Nicosia A, Cortese R, Leroux-Roels G, Balfe P, Bienkowska-Szewczyk K, Meuleman P, McKeating JA, Folgori A. J Virol; 2014 May 09; 88(10):5502-10. PubMed ID: 24599994 [Abstract] [Full Text] [Related]
15. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. Masavuli MG, Wijesundara DK, Underwood A, Christiansen D, Earnest-Silveira L, Bull R, Torresi J, Gowans EJ, Grubor-Bauk B. Front Immunol; 2019 May 09; 10():1145. PubMed ID: 31178869 [Abstract] [Full Text] [Related]
16. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Bellier B, Dalba C, Clerc B, Desjardins D, Drury R, Cosset FL, Collins M, Klatzmann D. Vaccine; 2006 Mar 24; 24(14):2643-55. PubMed ID: 16481074 [Abstract] [Full Text] [Related]
19. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM. J Infect Dis; 2000 Jul 24; 182(1):18-27. PubMed ID: 10882577 [Abstract] [Full Text] [Related]
20. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations. Gordon EJ, Bhat R, Liu Q, Wang YF, Tackney C, Prince AM. J Infect Dis; 2000 Jan 24; 181(1):42-50. PubMed ID: 10608749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]